Brand | Abnova |
Product type | Primary antibodies |
Reactivity | Human,Mouse,Primates,Rat |
Host species | Rabbit |
Applications | IP,ELISA,ChIP,IHC-Fr,ICC,GSA,WB-Ce,IHC-P,IF,Flow Cyt |
Brand: | Abnova |
Reference: | PAB12124 |
Product name: | EPAS1 polyclonal antibody |
Product description: | Rabbit polyclonal antibody raised against synthetic peptide of EPAS1. |
Gene id: | 2034|13819 |
Gene name: | EPAS1 |
Gene alias: | ECYT4|HIF2A|HLF|MOP2|PASD2|bHLHe73 |
Gene description: | endothelial PAS domain protein 1 |
Immunogen: | A synthetic peptide corresponding to C-terminus of human and mouse EPAS1/Epas1. |
Protein accession: | P97481 |
Form: | Liquid |
Recommend dilutions: | ChIP (1:10-1:500) ELISA (1:100-1:2000) Flow Cytometry Gel Supershift Assay Immunocytochemistry (1:100) Immunofluorescence (1:100) Immunohistochemistry (Frozen sections) Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sectio |
Storage buffer: | In PBS (0.05% sodium azide) |
Storage instruction: | Store at -20°C. Aliquot to avoid repeated freezing and thawing. |
Note: | This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only. |
Product type: | Primary antibodies |
Host species: | Rabbit |
Antigen species / target species: | Human,Mouse |
Specificity: | Specific for HIF-2 alpha/EPAS. Does not cross-react with HIF-1 alpha. |
Reactivity: | Human,Mouse,Primates,Rat |
Application image: | ![]() |
Application image note: | Western Blot analysis of (1) Cobalt chloride treated COS-7 nuclear extracts and (2) untreated COS-7 nuclear extracts with EPAS1 polyclonal antibody (Cat # PAB12124). |
Applications: | IP,ELISA,ChIP,IHC-Fr,ICC,GSA,WB-Ce,IHC-P,IF,Flow Cyt |
Shipping condition: | Blue Ice |
Publications: | Red wine polyphenols prevent acceleration of neovascularization by angiotensin II in the ischemic rat hindlimb.Walter A, Etienne-Selloum N, Brasse D, Schleiffer R, Bekaert V, Vanhoutte PM, Beretz A, Schini-Kerth VB. J Pharmacol Exp Ther. 2009 May;329(2):699-707. Epub 2009 Feb 4. |